Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who ...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world, we'd like to see a company investing more capital into its business and ideally ...

Delfi (SGX:P34) has had a rough month with its share price down 5.8%. But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see an ...

CHICAGO — Delfi Diagnostics, a company seeking to develop liquid biopsy tests to help screen for lung cancer, published a scientific paper on Monday describing key aspects of the test and unveiled the ...

NEW YORK--(BUSINESS WIRE)--As financial institutions continue to navigate increasing uncertainty, Delfi, an AI-native risk management platform, and CFO Consulting Partners LLC (CFOCP), a team of ...

The Remington-based startup was founded by Johns Hopkins oncology professor Dr. Victor Velculescu, who also cofounded Canton's Personal Genome Diagnostics. Inside FastForward 1812, an East ...

PALO ALTO, Calif. and BALTIMORE, Feb. 1, 2024 /PRNewswire/ -- DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, today announced ...

MANILA, Philippines - After conquering the world market for chocolate products, Delfi, a top chocolate confectionery brand, is set to make ripples in the country as it brings its world class-quality ...

NEW YORK--(BUSINESS WIRE)--Delfi, a machine-learning risk management platform for financial institutions, has partnered with three U.S. banks to revolutionize interest rate risk management.